Skip to main content

Table 1 Significance of variations of the parameters amongst the experimental groups

From: Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice

Vs D2-OID VD3 D2-OID + VD3
D2-specific IgG2a (serum)
 Sham n.s. * **
 D2-OID   * **
 VD3    *
IL-4 (BALF/lung homogenate)
 Sham * * **
 D2-OID   n.s. *
 VD3    *
IL-13 (BALF/lung homogenate)
 Sham n.s n.s. **
 D2-OID   n.s. *
 VD3    n.s.
IL-10 (BALF/lung homogenate)
 Sham * ** ***
 D2-OID   * **
 VD3    *
IFN-γ (BALF/lung homogenate)
 Sham n.s. n.s. *
 D2-OID   n.s. n.s.
 VD3    n.s.
TNF-α (BALF/lung homogenate)
 Sham * * **
 D2-OID   n.s. n.s.
 VD3    n.s.
IL-6 (BALF/lung homogenate)
 Sham n.s. n.s. *
 D2-OID   n.s. n.s.
 VD3    n.s.
Treg (FoxP3+ CD25+  % of CD4+, spleen)
 Sham * ** **
 D2-OID   * *
 VD3    n.s
Treg (FoxP3:CD3, lung)
 Sham * * ***
 D2-OID   n.s. **
 VD3    **
Eosinophils (lung)
 sham n.s. P = 0.02 (0.01)**
 D2-OID   (0.05)* P = 0.02
 VD3    P = 0.051
  1. *p < 0.05, **p < 0.01, ***p < 0.001